‘Russian market, Russian drugs’: New pro-generic moves reveal Medvedev’s intent
This article was originally published in Scrip
Executive Summary
The Russian government is planning to implement a number of pro-generic medicine policies, including a new requirement for doctors to prescribe all medicines by their international non-proprietary name (INN) by July 2013, and a drive to improve the quality of generic versions of originator drugs.